Access to prenatal exome sequencing for fetal malformations: A qualitative landscape analysis in the US.

Further integrating the perspectives of additional key stakeholders are important for understanding clinical utility, developing policies and practices to address access barriers, and assuring equitable provision of prenatal diagnostic testing.